Developmental/Behavioral Disorders

What are the unique challenges for individuals with ADHD?

Some of the more severe attention-deficit/hyperactivity disorder (ADHD) symptoms noted were depression/withdrawal, problems with socialization.

A recent study found a negative association between children with attention-deficit/hyperactivity disorder (ADHD) and health eating patterns.

At the 2022 Pediatric Academic Societies Meeting, Christopher Golden, MD, presented on 2 topics focused on DEI.

At the 2022 Pediatric Academic Societies meeting, Shruti Mittal, MD, FAAP, looked at how many children with attention-deficit/hyperactivity disorder get started on behavioral therapy before medication in the preschool years.

At the 2022 Pediatric Academic Societies meeting, Samuel Akaakole Mensah shared results of a 10-year study on pediatric hospitalization trends for cannabis use disorder.

At the 2022 Pediatric Academic Societies meeting, Bradley Kerr, MS shared research on how adolescents really feel about TikTok when it comes to mental health support and peer comparison.

Recent research suggests females with autism may need their own set of parameters on which to be measured.

Dana Suskind, founder and co-director of the TMW Center for Early Learning + Public Health, Director of the Pediatric Cochlear Implant Program, and professor of Surgery and Pediatrics at the University of Chicago in Illinois, discusses her new book, published by Dutton/Penguin, focused on how parents can raise children who are well-developed in their cognitive and socioemotional skills.

At the 43rd National Conference on Pediatric Health Care for pediatric nurse practitioners in Dallas Texas, 2 clinicians shared their insights on how primary care providers can screen, diagnose, and treat eating disorders in children and adolescents.

Learning vocabulary to advocate for equity, and provide actionable tools for nurse practitioners to confront and dismantle health disparities was this keynote speaker's topic at the 43rd National Conference on Pediatric Health Care for pediatric nurse practitioners in Dallas, Texas.

The “Learn the Signs, Act Early” Program, an effort of the Centers for Disease Control and Prevention (CDC) and the American Academy of Pediatrics (AAP), updates developmental surveillance tools to promote timely surveillance and intervention.

Catch up on all the latest in ADHD from the The American Professional Society of ADHD (attention-deficit/hyperactivity disorder) and Related Disorders (APSARD) virtual 2022 Annual Meeting.

Prompt diagnosis of autism spectrum disorder can improve outcomes, but are young children getting the necessary screenings when they should?

Eating disorders carry many risks. An investigation looks into whether they can increase the risk of certain neurodevelopmental conditions in the children of mothers with a history of eating disorders.

Understanding the population characteristics of neurodevelopmental disorders is an important way to find modifiable risk factors and help determine needed services.

Steven Selbst, MD, comments on a new study showing the devastation of gun violence in low-income communities.

In a clinical study of healthy adults, Dyanavel XR tablets were deemed to be bioequivalent to amphetamine extended-release oral suspension in patients with attention-deficit/hyperactivity disorder (ADHD) by the US Food and Drug Administration (FDA).

Dr. Tan shares her must-reads from the October issue.

New technology-based tools can help pediatricians to make an accurate diagnosis of autism spectrum disorder.

At the virtual 2021 American Academy of Pediatrics National Conference & Exhibition, Hilary McClafferty, MD, FAAP, discusses evidence-based management tools to relieve stress and burnout for pediatricians.

Using bell and pad alarm therapy is a typical therapy for enuresis in children, a study examines its efficacy in those with neurodevelopmental disorders.

A study has found that prenatal analgesic opioid exposure of 5 or more weeks is associated with a slightly elevated risk of attention-deficit/hyperactivity disorder (ADHD) in children compared to exposure of 4 weeks or less.

The pandemic caused the shut down of schools and resulted in virtual learning for most of the world's children and adolescents. How did they fare?

AZSTARYS (serdexmethylphenidate and dexmethylphenidate) is available for prescription to help provide rapid and extended duration of attention-deficit/hyperactivity disorder (ADHD) symptoms.

As more extremely preterm infants survive delivery, a study examines whether the advances that allowed for that survival also improve neurodevelopmental outcomes.

Although too much screen time isn’t beneficial to any child, could the developmental and behavioral impact of this be exacerbated in a child who was born at less than 28 weeks?

A study examines the effect of after-school activity participation on a child's attention-deficit/hyperactivity disorder (ADHD) severity.

Global prevalence of autism spectrum disorder is 1% to 2%, but little research has been done in non-White populations. An investigation offers some much-needed insight.

Stimulants are recommended as the first-line treatment for attention-deficit/hyperactivity disorder (ADHD). A study examines whether α2-adrenergic agonists could be effective as well.